Mwf

Chemo Secrets From a Breast Cancer Survivor

Breast Cancer Survivors

Get Instant Access

Treatment for Patients with Intermediate-Risk, Unfavorable Biology

These patients should receive an additional four cycles of chemotherapy in course II as follows:

Course number Cycle number Day Agents (in doses listed earlier)

II 5 84-86 Repeat chemotherapy drugs in cycle 3

6 105 Repeat cycle 2

7 126-128 Repeat cycle 1

8 147 Cyclophosphamide and doxorubicin

Growth factors (G-CSF or GM-CSF) should be given for infants less than 60 days of age. Older infants and children may also receive growth factors. G-CSF 5 mg/kg/day Subcutaneously (SC) or GM-CSF 250 mg/m2/day SC starting 24 hours after chemotherapy administration until the absolute neutrophil count is >1,000/pL for 2 consecutive days. Estimated 3-year relapse-free survival is 75-98%.

Was this article helpful?

0 0

Post a comment